Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Vigil Neuroscience, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 35 | 33 | −2 |
| Shares | 17.3M | 24.6M | +7.21M (+41.6%) |
| Value | $44.6M | $222.7M | +$178.1M (+399.5%) |
New holders (6)
Institutions that held Vigil Neuroscience, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 2,054,794 | $18.0M | 0.36% |
| BVF Inc | 1,813,633 | $16.5M | 0.68% |
| Ergoteles LLC | 28,533 | $260.0K | 0.01% |
| Altium Capital Management LP | 15,788 | $144.0K | 0.05% |
| Royal Bank of Canada | 1,000 | $9.00K | 0.00% |
| State of Wyoming | 46 | $0 | 0.00% |
Sold out (8)
Institutions that held Vigil Neuroscience, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Renaissance Technologies LLC | 37,488 | $97.0K |
| LMR Partners LLP | 25,337 | $65.0K |
| Point72 Hong Kong Ltd | 12,139 | $31.0K |
| UBS Group AG | 2,448 | $6.00K |
| Cubist Systematic Strategies, LLC | 1,118 | $3.00K |
| New York State Common Retirement Fund | 59 | $0 |
| Credit Suisse AG | 4 | $0 |
| PEAK6 Investments LLC | 14,337 | – |